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Abstract
The intestine is a common site for invasion by intracellular pathogens, but little is known about how pathogens restructure
and exit intestinal cells in vivo. The natural microsporidian parasite N. parisii invades intestinal cells of the nematode C.
elegans, progresses through its life cycle, and then exits cells in a transmissible spore form. Here we show that N. parisii
causes rearrangements of host actin inside intestinal cells as part of a novel parasite exit strategy. First, we show that N.
parisii infection causes ectopic localization of the normally apical-restricted actin to the basolateral side of intestinal cells,
where it often forms network-like structures. Soon after this actin relocalization, we find that gaps appear in the terminal
web, a conserved cytoskeletal structure that could present a barrier to exit. Reducing actin expression creates terminal web
gaps in the absence of infection, suggesting that infection-induced actin relocalization triggers gap formation. We show
that terminal web gaps form at a distinct stage of infection, precisely timed to precede spore exit, and that all contagious
animals exhibit gaps. Interestingly, we find that while perturbations in actin can create these gaps, actin is not required for
infection progression or spore formation, but actin is required for spore exit. Finally, we show that despite large numbers of
spores exiting intestinal cells, this exit does not cause cell lysis. These results provide insight into parasite manipulation of
the host cytoskeleton and non-lytic escape from intestinal cells in vivo.
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Introduction
Intracellular pathogens have a life cycle that includes three major
steps: invasion of the host cell, replication, and exit out of the host
cell. While the question of how pathogens invade cells has been
intensively studied, much less is known about how pathogens exit
cells, although this process appears to be highly regulated [1]. Even
when pathogen exit causes lysis of hostcells, this lysis is often due not
simply to mechanical stress, but is part of a regulated process
controlledbythepathogen.Forexample,theintracellularbacterium
Chlamydia uses a cysteine protease to lyse host cells at the proper time
as a mechanism of escape [2]. In addition to lytic escape, there are
also less destructive modes of pathogen exit. One example of non-
lytic pathogen exit comes from the Gram-positive bacterium Listeria,
which polymerizes host actin to force its way into neighboring cells,
which then engulf the bacterium to allow cell-to-cell spread [3].
Another example of non-lytic pathogen exit involving actin is used
by Mycobacterium [4,5].In contrastto Listeria, Mycobacterium appears to
break through the host plasma membrane as it is exiting, and the
membrane reseals behind the pathogen such that the host cell is not
lysed. Acquiring a better understanding of the mechanisms of
pathogen exit in vivo could lead to better treatments in a variety of
settings, since the process of exit is critical for the propagation and
spread of intracellular pathogens of all types.
Many intracellular pathogens invade their host and progress
through infection in the intestine. However, most studies of
pathogen exit have been performed in tissue culture cells or single-
celled hosts, such as the studies described above. Unfortunately,
these model hosts lack the connectivity, differentiated structures,
and polarity of intact intestinal cells. The Caenorhabditis elegans
intestinal tract provides an excellent system to study intestinal
pathogens as it is composed of 20 epithelial cells that share many
morphological properties with human intestinal epithelial cells [6].
In both humans and worms, the intestine contains polarized
epithelial cells decorated with apical, finger-like microvilli
anchored into a cytoskeletal structure called the terminal web,
which is composed of actin and intermediate filaments. Because C.
elegans intestinal cells share these structural similarities with human
intestinal epithelial cells and because nematodes are transparent,
C. elegans provides a very useful whole-animal model for study of
host/pathogen interactions in intestinal epithelial cells [7,8].
Recently, we described the first natural intracellular pathogen of
C. elegans and found that it defines a new species of microsporidia
[9,10]. Microsporidia are obligate intracellular parasites that can
infect virtually all animal phyla, as well as a few protists [11,12,13].
These parasites comprise a phylum that is either part of the fungal
kingdom or is a sister group to the fungi [14,15,16,17]. The
Microsporidia phylum contains over 1200 species, 14 of which can
cause infection in humans. These infections most commonly afflict
AIDS patients and other immunocompromised patients where
they can cause persistent and lethal diarrhea [18]. Because so little
is known about these microbes and few treatments are available,
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Institutes of Health. Microsporidia are also considered microbial
contaminants of concern by the U.S. Environmental Protection
Agency and can plague agriculturally relevant organisms. For
example, microsporidia have been responsible for the collapse of
fisheries and have also been implicated in honey bee colony
collapse disorder [19,20,21,22]. We named the C. elegans-infecting
microsporidia species Nematocida parisii, or nematode-killer from
Paris, since it was first isolated from a French wild-caught
nematode and it eventually kills its host.
The microsporidia are a diverse group of pathogens that can
have very complex life cycles. On a general level, the N. parisii life
cycle appears similar to that of other microsporidia (Figure 1A)
[9,13]. N. parisii infects the C. elegans intestine in its transmissible
spore form and is transmitted horizontally, likely via a fecal-oral
route. After ingestion, microsporidia invade host cells using a
specialized infection apparatus called a polar tube, which is coiled
inside of the spore and then ‘‘fires’’ to pierce the host cell. The
polar tube can inject the nuclei and sporoplasm of the parasite
directly into host cells, thereby avoiding extracellular defenses of
the host. This injected parasite material develops intracellularly in
a replicating cellular structure called a meront. These meronts go
through several stages of development and eventually re-
differentiate to generate mature spores that somehow must exit
the cell and continue the parasite life cycle. N. parisii ultimately kills
Author Summary
The intestine is a common site for invasion by pathogens,
but little is known about how pathogens exit out of live
intestinal cells in order to spread and propagate. One
group of parasites that often invades the intestine is the
microsporidia, which comprise a phylum of over 1200
fungal-like species that can cause disease in humans, as
well as in agriculturally significant organisms such as fish,
silkworm and honey bee. Here, we investigated a natural
microsporidian infection in live intestinal cells of the
roundworm C. elegans. We discovered a novel exit strategy
used by microsporidia to restructure the cytoskeleton of
intestinal cells, involving relocalization of actin and
reorganization of a structure called the terminal web,
which may be a barrier to exit. In addition, we found that
despite large numbers of parasites exiting out of intestinal
cells, this process does not cause cells to burst. Our
findings indicate that microsporidia, which are completely
dependent on their hosts for replication, have evolved
a regulated and non-damaging mechanism of exit that
shares similarities with strategies used by evolutiona-
rily distant bacterial pathogens. This study provides
new insights into the methods by which pathogens
restructure live intestinal cells to facilitate their spread
and propagation.
Figure 1. Microsporidian lifecycle and anatomy of C. elegans intestinal cells. (A) Generalized microsporidian life cycle inside a host cell. (B)
Two dimensional (2D) view of the C. elegans intestine. The intestine is formed of polarized epithelial cells, mostly in rings of 2 cells each. On the apical
(lumenal) side of these cells are actin-rich microvilli that are anchored into the terminal web, which is composed of actin (ACT-5) and intermediate
filaments (IFB-2). (C) Three dimensional (3D) view of three rings of the C. elegans intestine (int2, 3, 4), two cells in each ring (other rings not shown for
simplicity).
doi:10.1371/journal.ppat.1002227.g001
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death. Indeed, live animals can be contagious to their neighbors,
indicating that there is a mechanism of exit that does not cause
severe damage to the host. Previously, we had observed gaps in the
intermediate filaments of the terminal web in infected animals and
hypothesized that they may be part of a regulated exit strategy of
N. parisii [9]. However, we did not know what initiated these gaps,
nor how they related to pathogen development and exit.
Here we show that N. parisii infection causes dramatic
rearrangement of intestinal actin that is part of a novel two-phase,
non-lytic exit strategy. The first phase involves restructuring of the
terminal web, which is a barrier that pathogens must cross to exit
cells. During this phase the subcellular localization of actin is
altered, with the apically-restricted actin appearing ectopically on
the basolateral side of host cells and forming networks.
Subsequently, gaps appear in the terminal web, as assessed by
IFB-2, an intermediate filament component of the terminal web.
We hypothesize that actin redistribution away from the apical
membrane may trigger these gaps in the terminal web, since
lowering actin levels causes terminal web gaps in the absence of
infection. Soon after the appearance of gaps, the parasite enters
the second phase of the exit strategy. During this phase N. parisii
spores are able to exit the cell. Interestingly, we find that host actin
promotes spore exit and that decreasing the levels of actin impairs
spore exit. Our analyses of cell integrity indicate that despite very
large numbers of spores exiting C. elegans intestinal cells, these cells
do not lyse. We propose that a novel, two-phase, non-lytic exit
strategy allows N. parisii to escape from host intestinal cells while
minimizing damage to its host, thus increasing parasite transmis-
sion.
Results
C. elegans Actin Ectopically Relocalizes in Intestinal Cells
during N. parisii Infection
N. parisii infection proceeds through distinct stages in C. elegans
intestinal cells, starting with the meront stage when the parasite is
actively replicating (Figure 1A). N. parisii meronts appear to
develop in direct contact with the host cytoplasm, essentially
creating ‘‘parasite organelles’’, which eventually develop into
mature spores [9]. Both meronts and spores form inside C. elegans
intestinal cells, which are polarized epithelial cells that are found in
rings of two to four cells that form a tube [6]. Like mammalian
intestinal cells, these cells are decorated on the apical (lumenal)
side with microvilli that are anchored into a cytoskeletal structure
called the terminal web. The C. elegans terminal web contains a
specialized actin isoform called ACT-5 and an intermediate
filament component called IFB-2 (Figure 1B, C). ACT-5 is
restricted mostly to microvilli-containing cells and is localized to
both the microvilli and the terminal web [23], whereas IFB-2 is
restricted to the terminal web [24,25]. To examine how N. parisii
infection modifies the intestinal cytoskeleton, we generated a strain
that expresses YFP::ACT-5 as well as IFB-2::CFP in the intestine to
track both of these cytoskeletal components simultaneously. In
uninfected animals, we found that YFP::ACT-5 colocalized with
IFB-2::CFP at the apical side of intestinal cells (Figure 2A),
consistent with previous reports [24,25].
We next imaged these cytoskeletal components during infection
with N. parisii. Because N. parisii cannot be propagated outside of
host cells, we prepare infectious spores by mechanically disrupting
infected animals and purifying the spores away from other
material. By adding a preparation of these spores onto plates
regularly used to maintain C. elegans, the animals become infected
by simply ingesting the spores. Once ingested, the spores then
presumably fire their polar tubes, injecting N. parisii sporoplasm
and nuclei into the C. elegans intestinal cells. We investigated
cytoskeletal protein localization as N. parisii infection progressed
and found that infection with N. parisii caused dramatic changes in
ACT-5 localization without concomitant changes in IFB-2. The
first relocalization of ACT-5 occurred during N. parisii meront
development, which is the first stage of parasite development. At
this point, we found that ACT-5 localization no longer remained
restricted to the apical side of intestinal cells, but appeared
ectopically on the basolateral side of cells (Figure 2B). Coinciding
with this ectopic basolateral localization that appeared as an
unbranched line, we also observed more complex networks of
ACT-5 expression (Figure 2C). These networks exhibited branches
that varied in number and length, and also appeared basolaterally.
The exact molecular nature of these structures is unknown, so we
refer to them generally as ‘‘actin networks’’. They may be part of
the same basolateral relocalization phenomenon shown in
Figure 2B, but are more easily visualized in the plane of focus
shown in Figure 2D because of the orientation of the animal on
the slide. In both cases, actin still remained apically localized,
although often at lower levels. Videos S1 and S2 show a Z-series of
YFP::ACT-5 localization in the intestine to provide a three-
dimensional view of this actin relocalization phenomenon. In
general, we did not observe IFB-2 relocalizing with ACT-5
(Figure 2B and 2C), indicating that N. parisii infection directs a
specific relocalization of actin.
To determine whether these ectopic patterns of ACT-5
localization were general responses to pathogen infection or were
specific to N. parisii infection, we analyzed YFP::ACT-5 localization
in animals infected with other intestinal pathogens. The Gram-
negative bacterial pathogens Pseudomonas aeruginosa and Salmonella
enterica also cause lethal intestinal infections in C. elegans
[26,27,28,29]. We did not observe ectopic actin basolateral
localization or networks in animals infected with P. aeruginosa
(n=55 animals), or S. enterica (n=154 animals), indicating that the
previously described localization patterns are somewhat specific to
infection by the natural intracellular parasite N. parisii. We also
examined a larger number of uninfected animals and saw only one
out of 200 animals that had a single ectopic actin structure without
obvious branching, further supporting our finding that this
dramatic actin relocalization is specific to N. parisii infection.
Actin Relocalization Precedes Restructuring of
Intermediate Filaments in the Terminal Web
To further characterize this actin relocalization in infected
animals, we examined the kinetics of ACT-5 ectopic localization
with respect to changes in IFB-2 and to progression of N. parisii
development. We infected a synchronized population of YF-
P::ACT-5;IFB-2::CFP animals and tracked both N. parisii parasite
development and changes in these cytoskeletal markers in a
population over time (Figure 3). The stages of parasite develop-
ment are shown in Figure 3A–D. We subdivided the meront stage
into ‘‘early meront’’ (Figure 3B), where there was only a small area
of gut granule clearing in the intestine, and ‘‘late meront’’
(Figure 3C), where there was more extensive clearing throughout
the intestine. Following meront development, spores become
visible (Figure 3D). Early meronts appeared by 16 hours post-
inoculation (hpi), late meronts appeared by 30 hpi and spores
appeared by 40 hpi (Figure 3E). The first obvious change in the
cytoskeleton was the ectopic localization of YFP::ACT-5
(Figure 3E), appearing as a line on the basolateral side of intestinal
cells (as shown in Figure 2B). This pattern was observed in all
animals of a population during the late meront stage, at 30 hpi. In
addition to this linear basolateral relocalization, there was also
Non-Lytic Exit of Parasites from Intestinal Cells
PLoS Pathogens | www.plospathogens.org 3 September 2011 | Volume 7 | Issue 9 | e1002227evidence of ACT-5 networks at this time (Figure 2C and Video
S2), continuing at a low level until 40 hpi when all animals
contained spores.
We also examined how this ectopic actin localization correlates
with restructuring of the terminal web by assessing IFB-2
localization in these same animals. Previously, we had identified
gaps in the terminal web of infected animals using transmission
electron microscopy (TEM) and gaps in IFB-2 localization using
anti-IFB-2 antibodies [9]. Here, we found very similar-appearing
gaps in infected animals using CFP-tagged IFB-2 (IFB-2::CFP)
(compare uninfected animals in Figure 3F to heavily infected
animals in Figure 3G). We first observed these gaps in 13% of
animals infected at 30 hpi, the late meront stage of infection
(Figure 3E). At 40 hpi, when all animals were infected at the spore
stage, gaps were found in the terminal web of 100% of animals
(Figure 3E). Based on these observations, it appears that actin
relocalization occurs before IFB-2 restructuring during infection.
We saw a similar pattern of IFB-2 restructuring with respect to
parasite development in single IFB-2::CFP transgenic animals,
indicating that the presence of the YFP::ACT-5 transgene did not
affect IFB-2::CFP expression or localization (Figure S1).
The studies described above were performed with a population
of animals, which is informative, but does not provide insight into
the progression of symptoms within an individual animal. To
determine whether the trends we observed in a population (e.g.
ACT-5 is relocalized before IFB-2 localization is disrupted) were
Figure 2. Host intestinal actin relocalizes basolaterally during N. parisii meront development. (A) Uninfected animals have apical
colocalization of YFP::ACT-5 and IFB-2::CFP. (B) Meront-infected animals exhibit ectopic basolateral localization of YFP::ACT-5 (indicated by rightward
arrows), without concomitant IFB-2::CFP. Infected animals often exhibit additional involutions of the lumen as indicated by asterisks, and later during
infection exhibit gut distension (not shown). (C) Meront-infected animals exhibit ectopic YFP::ACT-5 networks (upward-pointing arrows), again in the
absence of IFB-2::CFP. Meronts are observed as clearings of gut granules, as indicated by arrowheads in Nomarski overlays of (B) and (C). Scale bar for
(A, B) is 20 mm, for (C) is 10 mm. (D) Diagram of the 2D planes of focus for (A–C) shown in the context of 3D intestinal cell rings.
doi:10.1371/journal.ppat.1002227.g002
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Individual animals were mounted on slides at varying timepoints
for viewing, and then recovered onto plates in between these
timepoints to allow them to recover and to allow the infection to
progress (Table S1). Consistent with the population studies, these
experiments showed that YFP::ACT-5 basolateral relocalization
occurred first, followed by gaps in IFB-2::CFP localization.
Our previous studies with IFB-2 antibodies had suggested that
terminal web gaps were specific to N. parisii infection – we did not
observe them in animals infected with other pathogens that cause
lethal intestinal infections, such as P. aeruginosa and Staphylococcus
aureus [9]. Using the IFB-2::CFP transgene we also analyzed the
terminal web in animals infected with the bacterial pathogen S.
enterica, but did not find evidence that infection caused gap
formation in the terminal web (n=154 animals). To further
confirm that terminal web gaps were a N. parisii-induced
phenotype, we used the IFB-2::CFP transgenic animals and
performed a thorough inspection of IFB-2 localization in
uninfected animals (n=200 animals). We found that only one
animal exhibited a gap, and this was a single, isolated gap. For our
analyses of N. parisii infected animals, we only scored animals as
positive for gap formation if we observed multiple gaps. Thus,
similar to the ACT-5 relocalization phenotype, the gaps observed
in IFB-2::CFP localization appear to be specific to N. parisii
infection.
Perturbations in Actin Can Cause Terminal Web Gaps in
the Absence of Infection
Since relocalization of ACT-5 during N. parisii infection
preceded the appearance of gaps in IFB-2 localization, we
hypothesized that reduced levels of ACT-5 in the apical
membrane might cause IFB-2 terminal web gaps. To test this
hypothesis we reduced ACT-5 expression with feeding RNA
interference (RNAi) against act-5. We observed a substantial
reduction in YFP::ACT-5 expression in act-5 RNAi-treated animals
compared to control-treated animals, confirming the efficacy of
act-5 RNAi (Figure 4A, B). Interestingly, when we analyzed the
terminal web in act-5 RNAi-treated animals we found gaps in IFB-
2::CFP that appeared in the absence of infection (Figure 4B).
Therefore, we speculate that infection-induced reduction of ACT-
5 at the apical membrane may be a triggering event that results in
the disruption of the terminal web.
All Contagious Animals Have Terminal Web Gaps, Which
Form during a Discrete Stage of Infection
Our studies of N. parisii parasite development and host cell
restructuring suggested that terminal web gap formation is an
important stage of the infection cycle. Therefore, we investigated
whether terminal web gaps have a functional role by examining
how they relate to spore exit. As a functional read-out for spore
exit, we tested the contagiousness of individual infected animals:
in order for an animal to be contagious, spores must exit
intestinal cells, leave the intestinal tract (likely through normal
defecation), and then be consumed by a neighboring animal. To
measure contagiousness, uninfected ‘‘recipient’’ animals were
exposed to individual infected ‘‘donor’’ animals for a defined
length of time. Each individual donor animal was then removed
and examined for stage of infection and whether it had gaps in
IFB-2::CFP localization. Several days later, recipient animals were
examined to determine whether they had become infected, thus
implying that the donor animal had shed spores and was
contagious. After testing 164 individual donor animals for
contagiousness, we found 87 animals that were contagious and
all of these animals had spores, consistent with previous studies.
Strikingly, we found that 100% of these contagious animals
exhibited terminal web gaps (Figure 5A), consistent with the
model that gaps are functionally related to spore exit. Of the
animals that were non-contagious, 12% of them exhibited a small
number of spores (and gaps). In previous studies we had found
that animals infected with only a small number of spores are not
always contagious, likely due to a low amount of spores being
shed before the donors were removed from the plate [9]. There
were also 9% of non-contagious animals that exhibited gaps but
only meronts (no spores), consistent with population studies that
indicated gaps appear slightly before spore formation (Figure 3E).
The remaining 79% of animals that were non-contagious
exhibited no gaps and only meronts (no spores). Since all
contagious animals exhibit terminal web gaps, these data support
the model that terminal web gaps may be a necessary part of
spore exit from the intestinal cells.
We next sought to determine whether new gaps are
continually being made during the course of infection, or
whether gap formation is a discrete event that occurs only once
during infection. In general, gaps first appeared in the region of
the intestine exhibiting the heaviest N. parisii infection and gaps
were always present in the region of intestine that had spores
(Table S1 and data not shown). To quantify the number of gaps
over time we chose a plane of focus with the largest number of
gaps from N. parisii spore-infected animals and counted the
number of gaps at 40 hpi, when they first are visible in all
animals, and again at 63 hpi. With this analysis, we found that
the number of gaps per unit area remained similar as the
infection proceeded, suggesting that new gaps are not made after
their initial formation at 40 hpi (Figure 5B). Next, we quantified
the size of gaps at 40 hpi and 63 hpi (see Figure legend and
Experimental Procedures for more detail on quantification).
With this analysis, we found that gaps became larger as the
infection proceeded, suggesting that once a gap is made it
becomes larger over time (Figure 5C). This effect may be due to
the lumenal distention that is observed as infection progresses, or
it may be due to a more active process. In any case, these data
indicate that the formation of gaps appears to be a discrete,
regulated event that is orchestrated by the parasite at a particular
stage in infection.
Figure 3. Actin relocalization occurs before terminal web restructuring. (A–D) Stages of N. parisii development during infection of C. elegans
intestine. Three arrows indicate the intestinal lumen and asterisk indicates the germ line. Scale bar is 50 mm. (A) Uninfected animal. (B) Animal
infected at early meront stage. Small number of meronts indicated with arrowhead. (C) Animal infected at late meront stage. Meronts are found
throughout the intestine; three examples are indicated with arrowheads. (D) Animal infected with spores. Bracket in D indicates region of intestine
filled with spores. (E) Kinetics of cytoskeletal restructuring and parasite development in a population of animals infected at time=0 hours. ACT-5
ectopic localization basolaterally and in branched networks occurs before the appearance of gaps in IFB-2 localization, which occur before and in
conjunction with N. parisii spore formation. Data shown are the average of three independent experiments with 50 animals scored at each timepoint
in each experiment (for a total of at least 150 animals scored at each timepoint). Error bars are SD. (see Table S1 for separate longitudinal infection
studies of ACT-5 and IFB-2 in individual animals over time). (F) Uninfected animals exhibit uniform expression of IFB-2::CFP in the terminal web on the
apical side of intestinal cells. (G) N. parisii infection causes gaps in IFB-2::CFP expression in the terminal web. Arrow indicates gaps in IFB-2::CFP, bracket
indicates N. parisii spores. Scale bars in (F, G) are 10 mm.
doi:10.1371/journal.ppat.1002227.g003
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The extensive relocalization of ACT-5 during infection and the
induction of gaps in IFB-2 localization upon RNAi against act-5
led us to investigate the functional role of ACT-5 during infection.
First, we assessed whether reducing levels of actin would affect the
development of N. parisii infection inside intestinal cells. We
measured the progression of N. parisii infection in animals fed with
bacteria expressing dsRNA against act-5. Because feeding
undiluted act-5 dsRNA-expressing bacteria can slow the growth
of animals, we titrated back the dose of RNAi to allow animals to
develop more normally. Diluting act-5 RNAi bacteria 1:25 and
1:50 with control bacteria allowed worms to develop relatively
normally, but still caused reduced act-5 levels (as assessed by
imaging YFP::ACT-5, Figure S2). We found that meronts and
spores appeared in act-5 RNAi-treated animals at a similar rate to
control-treated animals (Figure 6A). Therefore, despite the
changes induced in actin localization upon infection, reduction
of act-5 expression had no obvious effect on progression of N. parisii
infection or formation of spores within the host cells.
Sincereducingactininthe absence ofinfectioncausedgaps inthe
terminal web, which could be a barrier for exit, we speculated that
reducing actin might cause animals to shed more spores. Thus, we
sought to measure spore exit in act-5-defective animals. Previously,
we used single animal contagiousness assays to measure spore exit
(Figure 5A). However, these assays are labor-intensive and
categorical (animals are binned as either contagious or non-
contagious). Therefore, we developed a more quantitative ‘‘spore
shedding’’ assay to measure the number of spores shed by a
population of animals. Fifty infected animals were placed in liquid
media containing E. coli (the normal food source of C. elegans)a n d
allowed to shed spores into the media. After defined periods of time,
the number of spores shed was quantified. Animals appeared to
shed spores throughout the assay, as we found increasing numbers
of spores were shed with increasing amounts of time (Figure 6B).
Under these assay conditions we found that a single infected worm
could produce thousands of spores per hour. However, the number
of spores shed per animal had significant animal-to-animal
variability (data not shown), so we performed assays with
populations of animals. Using this assay, we tested whether
reducing ACT-5 levels would increase N. parisii spore shedding.
Surprisingly, we found that spore shedding was almost completely
blocked in 1:25 act-5 RNAi-treated animals and was substantially
blocked in 1:50 act-5 RNAi-treated animals compared to control-
treated (L4440) animals (Figure 6C). These findings suggest that
reduction of ACT-5 impairs spore exit, in contrast to our original
hypothesis. Altogether, our experiments indicate that proper levels
of hostactin are not important for N. parisii development inside cells,
but are critical for promoting spore exit from those cells.
To further test the hypothesis that actin promotes spore exit we
examined two other C. elegans strains that have differing levels of
act-5 expression. First, we examined the YFP::ACT-5 transgene,
which likely overexpresses actin. Our experiments indicated that
YFP::ACT-5 had no effect on the levels of spore shedding in our
assays compared to wild-type animals (Figure 6D). Next we
examined the act-5(ok1397) deletion mutant, which is likely a null
mutation, as it deletes half of the 59 translated region of act-5 as
Figure 4. Reducing expression of actin causes terminal web gaps in the absence of infection. (A) Expression of YFP::ACT-5 and IFB-2::CFP
in control (L4440 vector alone) RNAi-treated animals. (B) act-5 RNAi reduces expression of YFP::ACT-5 and causes gaps in IFB-2::CFP expression in the
absence of infection, as indicated by arrow. Exposure times were the same between (A) and (B). Scale bar is 20 mm.
doi:10.1371/journal.ppat.1002227.g004
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(A) Single animal contagiousness assays. Individual ‘‘donor’’ infected IFB-2::CFP animals were tested for contagiousness by exposing them to
‘‘recipient’’ uninfected animals. Donors were examined for IFB-2::CFP terminal web gaps and scored for stage of infection. 100% of contagious animals
exhibited gaps in IFB-2::CFP localization and N. parisii spores. (B) The number of gaps in IFB-2::CFP localization does not change over time. Each
datapoint represents one animal (n=20 animals at each timepoint) where the number of gaps was counted in a defined region of the intestine to
calculate the number of gaps/mm
2. Average number of gaps at 40 hpi is 0.19 gaps/mm
2 and at 63 hpi is 0.18 gaps/mm
2 (difference is not significant,
p=0.64, two-tailed t-test). (C) The size of gaps in IFB-2::CFP localization increases with time. Each datapoint represents the area of one gap, with
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5(ok1397) mutation is lethal when homozygous, we examined
spore shedding in act-5(ok1397)/+ heterozygote mutants, which
develop normally. We infected these animals with N. parisii and
found that spore development proceeded at a similar pace as in
wild-type animals (data not shown). Interestingly, in act-5
heterozygote mutants where act-5 expression should be reduced
to half of wild-type levels, we found that spore shedding was
approximately half of wild-type levels (Figure 6D), consistent with
our hypothesis that actin promotes exit. This result suggests that
there is a dose-dependent effect of actin on spore shedding, and
that proper levels of actin are critical for efficient N. parisii spore
exit from host cells.
Spores Exit Apically from Intestinal Cells and Appear to
be Free of C. elegans Membrane
The spore shedding and contagiousness assays described above
measure the spores that have left the animal, presumably through
defecation. Before these spores are shed through defecation, they
must first exit the intestinal cells into the lumen. Our previous
studies indicated that spores are only found in intestinal cells, and
spores are therefore unlikely to exit out of cells basolaterally to
enter the rest of the animal (e.g. into the gonad). To more closely
examine that spores only exit apically as opposed to basolaterally,
we performed transmission electron microscopy (TEM) to analyze
the location of spores in the whole animal. The only tissue in
which we conclusively found spores was the intestine (Figure 7A);
several gaps quantified per infected animal. At 40 hours post-inoculation (hpi) n=119 gaps and n=20 animals; at 63 hpi n=144 gaps and n=20
animals. Average gap size at 40 hpi is 0.87 mm
2 and at 63 hpi is 2.45 mm
2 (*** difference is significant, p,10
27, two-tailed t-test). See Materials and
Methods for more details on the quantitation method. Data graphed in Figure 5B and C are the combination of two independent experiments: 1) A
population study examining two different sets of animals at each timepoint (Table S2), and 2) A longitudinal experiment where we followed single
animals at two time points during infection and quantified the gaps in each animal (Table S3). We saw very similar trends within individual animals as
we saw within a population of animals in that the number of gaps did not change over time, but gaps increased in size.
doi:10.1371/journal.ppat.1002227.g005
Figure 6. Host actin is required for spore shedding. (A) Infection kinetics in RNAi-treated animals. N. parisii development proceeds similarly in
control (L4440) and act-5 RNAi-treated animals. Results are representative of three independent experiments, with at least 25 animals in each
condition of each experiment. (B) Spore shedding assay shows increasing number of spores shed by animals over time. Error bars are SD to show
variance in assay. (C) act-5 RNAi inhibits spore shedding, compared to control (L4440) treated animals. 1:25 diluted act-5 RNAi inhibits shedding more
than 1:50 diluted act-5 RNAi. Animals shed spores for 16 hours in this assay. (D) YFP::ACT-5 animals shed the same number of spores as wild-type
animals, while act-5(ok1397)/mT1[dpy-10(e128)] heterozygote mutants shed 50% fewer spores than wild-type animals. Animals shed for 13 hours in
this assay. (C-D) Number of spores shed per worm is the average of three replicates in a single experiment (with 50 animals tested in each replicate),
error bars are SEM. Results are representative of three independent experiments. (*** indicates p,0.0005, ** indicates p,0.002, two-tailed t-test).
doi:10.1371/journal.ppat.1002227.g006
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PLoS Pathogens | www.plospathogens.org 9 September 2011 | Volume 7 | Issue 9 | e1002227Figure 7. N. parisii spores exit apically out of intestinal cells and are not labeled with a C. elegans membrane marker. (A) TEM indicating
N. parisii spores inside intestinal cells and the intestinal lumen. Intestinal cells are false colored yellow (labeled I), the intestinal lumen and microvilli
are false colored red (labeled L), the gonad is false colored green (labeled G) and body wall muscle is false colored purple (labeled M). Examples of
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hypodermis, muscle or gonad). In order to further examine spore
location throughout the animal, we also fixed animals and stained
with Calcofluor White, a dye that binds to the chitin found in N.
parisii spores. Again, we only found evidence of N. parisii spores in
the intestine, not in other regions of the animal (Figure 7B).
Because N. parisii spores have to cross the C. elegans apical plasma
membrane of intestinal cells to exit into the lumen, we investigated
whether spores in the lumen may have acquired C. elegans plasma
membrane upon exit. To address this question we infected
transgenic animals expressing PGP-1::GFP, which is a GFP-tagged
ATP binding-cassette (ABC) transporter that localizes to the apical
side of intestinal cells [30]. After infecting worms, we transferred
them repeatedly away from spores onto fresh plates, so that any
spores in the lumen were likely the result of exit and not the result
of consumption (see Materials and Methods for details). We did
not find any lumenal N. parisii spores that were labeled with GFP
(Figure 7C, n=50 spores examined), suggesting that spores do not
take C. elegans membrane with them when they exit into the lumen.
N. parisii Spores Can Exit Intestinal Cells without Causing
Lysis
It is clear that N. parisii spores are exiting while animals are still
alive, as live animals are contagious to other animals ([9] and
Figure 5A) and animals are alive at the end of spore shedding
assays (Figure 6). However, it is unclear whether this process of
spore exit causes tissue damage that leads to cell lysis. To address
this question, we next examined whether N. parisii spore exit and/
or terminal web restructuring cause disruption of cellular integrity
of the intestinal cells. To assay cellular integrity, we used the cell-
impermeable dye propidium iodide (PI), which can be fed to C.
elegans. When intestinal cells are intact, PI does not enter cells after
short incubation periods, but instead remains restricted to the
intestinal lumen. As a positive control for PI entry into cells that
have lost integrity, we used animals that were exposed to the
Bacillus thuringiensis pore-forming toxin Cry5B, which creates
nanometer-sized holes in the plasma membrane. A recent study
demonstrated that Cry5B treatment of C. elegans creates pores in
intestinal cells that allow PI to enter intracellularly [31]. Consistent
with these studies, we found that animals fed E. coli that expresses
Cry5B had intracellular PI staining whereas animals fed normal E.
coli did not (compare Figure 8A and B). Strikingly, animals infected
with N. parisii (also fed on E. coli) did not exhibit intracellular PI,
indicating that cellular integrity was not compromised (Figure 8C
and G). These animals were infected with N. parisii spores
(Figure 8H), and exhibited gaps in IFB-2::CFP localization
(Figure 8I). In order to quantify this effect, we scored the
percentage of animals with intracellular PI in 100 animals of each
condition, only choosing animals that were infected throughout
the intestine with spores for the N. parisii infection condition. From
single-animal contagiousness assays with animals at a similar stage
of infection (Figure 5A), we estimate that 80-90% of these animals
were contagious. In these studies we found that almost all Cry5B-
treated animals exhibited intracellular PI, whereas virtually none
of the N. parisii-infected animals did (Figure 8J). Thus, while N.
parisii infection causes gaps in the terminal web and results in the
passage of 1 mm-wide N. parisii spores (much larger than Cry5B-
induced pores) across the membrane in order to exit into the
lumen, these events do not appear to cause lysis of C. elegans
intestinal cells. These data support the hypothesis that cytoskeletal
rearrangements and spore exit are highly regulated processes that
maintain the integrity of the host cell during infection.
Discussion
Intracellular pathogens have privileged access to host cell
components that they can exploit in order to survive, replicate,
and then exit to infect new hosts. The studies presented here
provide insight into parasite-directed cellular reorganization that
occurs in vivo in order to exit cells but minimize damage to the
host. We find that the intestinal parasite N. parisii redirects host
actin in order to non-lytically exit from intestinal cells and propose
a two-phase model for this exit, with terminal web restructuring
occurring during Phase I and non-lytic exit occurring during Phase
II (Figure 8K). Phase I takes place after invasion (step 1), when N.
parisii is developing as a metabolically active meront, a stage that
essentially forms a new organelle within the host cell. At this time,
the intestinal-specific actin isoform ACT-5 ectopically relocalizes
to the basolateral side of intestinal cells, often forming network-like
structures (step 2). Soon after this relocalization of ACT-5, gaps
appear in localization of IFB-2, an intermediate filament
component of the terminal web (step 3). We speculate that
relocalization of ACT-5 may trigger these gaps, since reducing the
level of ACT-5 expression causes gaps in the terminal web in the
absence of infection. We show that all contagious animals exhibit
gaps in localization of IFB-2, and that formation of gaps occurs
during a discrete stage of the infection cycle, suggesting that gap
formation is a highly regulated process. Phase II of the exit strategy
begins after N. parisii develops into spores and these spores exit out
of cells into the lumenal space (step 4). Surprisingly, we found that
reducing levels of ACT-5 impairs spore shedding, indicating that
host actin is required for proper exit of N. parisii spores at this
stage, even though the infection and parasite development can
proceed normally within the cell. Interestingly, N. parisii spore exit
is non-lytic, since extracellular dyes continue to be excluded from
the intracellular space of intestinal cells (step 5). This finding is
striking, as a single infected animal can shed thousands of spores
(Figure 6).
Our functional analyses of host intestinal actin during N. parisii
infection indicate that there are two distinct roles for actin, with
opposing effects in each of the two phases of exit. As described
above, it appears that host actin impairs exit during Phase I, since
a reduction of actin leads to gaps in the terminal web, which may
present a barrier to exit. However, we found that a reduction of
actin levels led to an overall reduction in spore exit. Thus, one
explanation is that host actin impairs spore exit during Phase I, but
promotes spore exit during Phase II. A caveat to this interpretation
is that the function of terminal web gaps (and thus the role of actin
in Phase I) is unclear since we do not yet have a method to block
gap formation during infection: it is possible that gaps serve a
purpose other than facilitating exit. Our proposed role of actin in
Phase II to promote exit also requires further investigation. One
possibility is that actin provides motor force to drive spores out of
intracellular spores in the intestinal cells are indicated with red upward arrows and an example of a lumenal extracellular spore is indicated with red
rightward arrowhead. Spores were only observed inside intestinal cells and in the intestinal lumen, suggesting that they only exit apically from
intestinal cells (not basolaterally). Scale bar is 10 mm. (B) N. parisii infected animal fixed and stained with Calcofluor White to label N. parisii spores
inside intestinal cells. Scale bar is 20 mm. (C) N. parisii spores in the intestinal lumen of PGP-1::GFP animals are free of GFP, suggesting that they did
not take C. elegans membrane upon exit into the lumen. Two spores in lumen are indicated with arrowheads. PGP-1::GFP labels the apical (lumenal)
side of two intestinal cells. Scale bar is 5 mm.
doi:10.1371/journal.ppat.1002227.g007
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PLoS Pathogens | www.plospathogens.org 11 September 2011 | Volume 7 | Issue 9 | e1002227Figure 8. Animals infected with N. parisii spores do not take up the extracellular dye propidium iodide. Propidium iodide staining in
uninfected animal (A, D), animal treated with Cry5B pore-forming toxin (B, E), and animal infected with N. parisii spores (C, F). Intestinal cells
encompass the entire space between the lumen (indicated with upward arrows) and the basolateral side of intestinal cells (indicated with outlines).
Outlines were drawn based on Nomarski images, which are shown in Figure S3 in order to better illustrate intestinal cell morphology. The intracellular
region is also indicated with an overlay the autofluorescence in the blue channel to indicate intracellular regions of intestinal cells (D–F). Note the
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relocalization at the proper time may be the key to orchestrating
the complex events that enable large numbers of microsporidian
spores to egress out of C. elegans intestinal cells in a manner that
minimizes damage to its host.
Understanding how N. parisii is able to exit the host cell
necessitates understanding what barriers it must cross and the
mechanism it employs to cross them. In Phase I of the N. parisii exit
strategy, the terminal web is restructured. Our studies indicate that
terminal web gaps appear right before spore formation (Figures 3E
and 5A), implying that gaps are not caused by the mechanical
process of spore exit, but rather by a regulated signaling event that
is precisely timed to precede spore formation and the need to exit.
The terminal web is a conserved structure found in microvilli-
containing cells from C. elegans to humans, but surprisingly little is
known about its assembly and dynamics [32,33,34,35]. The
terminal web presumably represents a barrier that host vesicles
must traffic through during normal endocytosis and exocytosis
events. Do intracellular vesicles need to dissolve the terminal web
in order to cross this barrier? Electron microscopy studies indicate
there are tiny gaps in the C. elegans terminal web that are too small
to allow for vesicle passage, but are associated with vesicular
elements and could represent a system of regulated passage [36].
Perhaps N. parisii is exploiting this vesicle passage system to create
gaps in the terminal web, but in a way that does not result in
resealing of these gaps. It will be interesting to perform live
imaging of the kinetics of these structures in uninfected animals to
examine what is the basal level of movement and restructuring of
this conserved structure in intestinal cells. It will also be interesting
to further examine the mechanism by which N. parisii spores cross
the plasma membrane, as our studies indicate that they do not
acquire C. elegans membrane as they exit into the lumenal space of
the intestine (Figure 7C).
In spite of the terminal web restructuring described above, and
the passage of 1 mm-wide spores out of cells into the digestive tract,
cellular integrity assays indicate that actin-based exit of N. parisii
spores does not cause lysis of C. elegans intestinal cells (Figure 8). This
finding is intriguing, since bacterial pathogens such as Listeria and
Mycobacteriumalsouse actin-based, non-lytic forms of exit, suggesting
a common evolutionary strategy for exit between eukaryotic and
prokaryotic pathogens. Severalbacterial virulencefactors havebeen
identified that direct these actin-based processes within host cells
[4,37], but comparatively little has been explored about eukaryotic
intracellular pathogens and the factors they use to exploit host cells.
And almost nothing is known about virulence factors in the
Microsporidia phylum. One of the few characterized examples of
microsporidian virulence factors is a class of ATP transporters that
can ‘‘steal’’ ATP from the host cell [14,38]. These transporters are
expressed on the plasma membrane of the parasite while it is living
inside the host cell and act to import ATP directly into the parasite.
In addition to this method of host exploitation, it is likely that
microsporidia also secrete factors from the meront into the host
cytoplasm to facilitate other kinds of nutrient acquisition, as well as
to direct the cytoskeletal changes we have observed. The N. parisii
genome has recently been sequenced (E.R.T. and the Broad
Institute, as part of the Microsporidian Genomes Consortium,
unpublished data, http://www.broadinstitute.org/files/shared/
genomebio/Microsporidia_wp.pdf) and may provide clues into
which parasite components are secreted into the host cell to direct
this restructuring.
We have isolated microsporidia-infected nematodes from a wide
variety of geographical locations, including multiple regions in
France (the N. parisii strain used in this study was isolated near
Paris), Portugal, India, Colombia and Cape Verde ([9] and Marie-
Anne Fe ´lix, personal communication). Thus, Caenorhabditis nem-
atodes have likely co-evolved with Nematocida and other microspo-
ridia species. Over time, co-evolution of host/parasite pairs is
thought to lead to a reduction in virulence [39,40]. This pressure is
likely to be especially great in obligate intracellular parasites such
as microsporidia, which cannot grow in the absence of host cells.
Microsporidian species that infect fish appear to have adopted a
strategy of minimal virulence in order to maximize parasite
production: they often form ‘‘spore factories’’ called xenomas in
the fish nervous system that can produce large numbers of spores
without substantial impact on the health of the fish [20]. Perhaps
the non-lytic exit of N. parisii is part of a strategy similar to the
xenomas found in fish that serves to maximize spore production
and transmission, but minimize virulence.
N. parisii likely has an intimate relationship with the C. elegans
intestinal cell during the meront stage, since it essentially creates a
parasite organelle that develops in direct contact with the host
cytoplasm [9]. The human-infecting microsporidian pathogen
Enterocytozoon bieneusi also develops in direct contact with the host
cytoplasm during the meront stage [41]. E. bieneusi infection in
humans is restricted to intestinal cells, and is the most common
cause of microsporidian disease in humans, being responsible for
lethal diarrhea in AIDS patients [18]. Effective treatments are
lacking for E. bieneusi infection [15,42] and it has not been possible
to propagate E. bieneusi in tissue culture cells, perhaps because
these cells lack some aspect of differentiated intestinal cells that is
needed for the infection cycle. While E. bieneusi and N. parisii are in
distinct clades of the microsporidia, their similar developmental
life cycle in the cytoplasm of intestinal cells may involve similar
pathogenic strategies. The C. elegans/N. parisii host/parasite system
may thus provide insights into the mechanisms employed by
medically relevant but intractable microsporidian species such as
E. bieneusi to further understand how they cause disease and
potentially how to treat the infections they cause.
Materials and Methods
Strains
C. elegans were maintained on NGM plates seeded with OP50-1,
as described [43]. We used N2 wild-type animals. BJ49 kcIs6[IFB-
2::CFP] was kindly provided by Olaf Bossinger. JM125 caIs[ges-
1p::YFP::ACT-5] was kindly provided by James McGhee [24].
extensive propidium iodide staining filling up the intracellular region in Panels B and E. (G) Propidium iodide staining in an N. parisii infected animal
with upward arrow indicating lumen. (H) Nomarski image of animal shown in G, arrowheads indicate N. parisii spores; (I) IFB-2::CFP of animal shown in
G and H, rightward-pointing arrow indicates gaps in the terminal web; Scale bar is 20 mm in A–I. (J) Percentage of animals with intracellular propidium
iodide shown as the average of 4 independent experiments, n=100 animals total for each condition, error bars are SD. The difference between
uninfected and Cry5B treated animals is significant, *** indicates p,10
26 with a two-tailed t-test. The difference between uninfected and N. parisii-
infected animals is not significant (p=0.36). (K) Model for actin-based, non-lytic N. parisii spore exit from C. elegans intestinal cells has two phases in
five steps: 1) N. parisii spores invade C. elegans intestinal cells, likely with polar tube. 2) N. parisii meronts develop and ACT-5 ectopically localizes to
the basolateral side of cell and in branched networks. This may lead to less expression on the apical side. 3) Gaps appear in the terminal web, then N.
parisii spores form. 4) Spores exit the cells, causing worms to be contagious. 5) Exit is non-lytic, because the extracellular dye propidium iodide is
unable to enter cells.
doi:10.1371/journal.ppat.1002227.g008
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and JM125 strains. A separately made YFP::ACT-5 strain, IN4000
dtIs2298, was kindly provided by James Waddle and used for
Videos S1 and S2. VC971 +/mT1 II; act-5(ok1397)/mT1[dpy-
10(e128)] III was provided by the C. elegans Reverse Genetics Core
Facility at UBC via the Caenorhabditis Genetics Center (CGC). The
presence of the act-5(ok1397) deletion was confirmed by PCR
genotyping. GK288 GFP::PGP-1 and E. coli (OP50)-Cry5B strains
were kindly provided by Ferdinand Los and Raffi Aroian. N. parisii
strain ERTm1 (isolated originally from Franconville, France, near
Paris) was used for all microsporidia infection experiments.
N. parisii Spore Preps
N. parisii infected animals were disrupted with silicon beads as
described [9]. This lysate was then filtered through a 5 mm filter
(Millipore) attached to a 10 ml syringe, to eliminate undisrupted C.
elegans eggs, larvae and other debris. The filtrate containing N.
parisii spores was frozen at 280uC and then thawed right before
use. N. parisii spores were quantitated by staining with Calcofluor
White (Fluka) and counting with a hemocytometer (Cell-Vu).
Infection Assays and Microscopy
In general, synchronized L1 larvae were grown for 24 hours on
10 cm NGM plates seeded with OP50 at 20uC until approximately
L3 stage, when they were infected with 3610
7 N. parisii spores and
then incubated at 25uC. Symptoms of infection were tracked by
mounting approximately 50 animals on agarose pads and then
viewing animals with Nomarski optics and/or fluorescence on a
Zeiss AxioImager at 630X magnification. Images were captured
with Axiovision software. P. aeruginosa PA14 infection assays and S.
enterica SL1344 infection assays were performed as described [44],
except that S. enterica infection assays included a pre-treatment with
bec-1 RNAi to knock down the autophagy pathway, as described
[29]. Transmission electron microscopy wasperformed as described
[9]. Calcofluor White staining on infected animals was performed
by fixing and staining with a 1:1 mix of 1M NaOH and Calcofluor
White. In order to examine spores that had newly exited into the
intestinal lumen (as shown in Figure 7C), animals were repeatedly
washed to reduce exposure to external spores they might ingest.
Specifically, at 24 hpi (prior to spore formation) animals were
washed four times in M9, added to fresh NGM plates seeded with
OP50, and incubated at 25uC until 40 hpi when this process was
repeated. To reduce the probability of animals consuming spores
shed by their neighbors, worms were replated at a low density of
approximately 45 worms per 6 cm plate. Lumen-localized spores
were then imaged in animals at 42 hpi.
Contagiousness Assays
Donor BJ49 [IFB-2::CFP] animals were generated for conta-
giousness assays as follows. Synchronized L1 larvae were grown on




5 spores diluted in
500 ml of M9 and placed at 20uCo r2 5 uC for 20 hours in order to
generate animals at a variety of infection stages. These animals
were picked to new NGM/OP50 plates without spores and
incubated for 4 hours, washed off the plate with M9, rinsed three
times to remove spores attached to the cuticle and then added to a
new plate. Next, these infected donor animals were individually
placed onto 6 cm NGM plates seeded with OP50 as well as 200 L1
recipient animals. The donor and recipient animals were co-
incubated for 16 hours and the donor animal was then removed to
assess infection level by mounting the animal on a slide and
scoring for meronts or spores using Nomarski optics, as well as
scored for gaps using fluorescence microscopy, at 630X. Recipient
animals were scored for infection similarly 7 days later. If no
infection was observed, plates were kept and then scored again for
infection 3 days later.
Characterization of Gaps in IFB-2::CFP Localization
Animals at 40 and 63 hours post-inoculation (hpi) were
analyzed. A 10 mm length of the intestine was chosen such that
the wall of the intestine was in a single plane of view. The width of
this 10 mm long section was measured and the total number of
gaps in IFB-2::CFP localization was counted to calculate the
number of gaps per mm
2. This area was then divided into 4
quadrants. In a single, randomly chosen quadrant, the area of
each individual gap within the quadrant was quantified using the
measure tool in AxioImager in order to calculate the average size
of gaps. Statistical comparisons of data at 40 hpi and 63 hpi were
done with a two-tailed t-test in Excel.
Longitudinal Infection Assays
ERT38 [IFB-2::CFP; YFP::ACT-5] synchronized L1 animals
were plated on NGM OP50 plates and infected with 3.6610
6
spores 24 hours later. In order to perform longitudinal analysis of
infection symptoms in the same animal over time, animals were
anesthetized with levamisole and mounted onto agarose slides for
scoring of symptoms, and then recovered onto NGM/OP50 plates
until the next timepoint.
RNA Interference Assays
Feeding RNAi was performed as described. Briefly, RNAi
bacterial clones were streaked onto LB agar plates with ampicillin
and tetracycline. A single colony was inoculated into LB with
ampicillin, grown overnight and then seeded on RNAi plates
(essentially nematode growth media with IPTG and ampicillin –
usually 6 cm plates). Plates were incubated for at least one day
before being seeded with a synchronized population of L1 C.
elegans. act-5 RNAi was either used undiluted, or diluted 1:25 or
1:50 with L4440 (vector alone) control RNAi bacteria. We
performed act-5 RNAi experiments either with a clone from the
Ahringer RNAi library or a clone that was a gift from James
Waddle [23]. RNAi clones were confirmed by sequencing. Similar
results were obtained with both clones, but in general, the
Ahringer clone caused more severe phenotypes.
Spore-Shedding Assays
Animals were infected with 4.5610
5 or 9.3610
5 N. parisii spores
on NGM plates seeded with E. coli OP50 and placed at 25uC. At
24 hpi, animals were washed with M9 and transferred to new
NGM OP50 plates (except when performing RNAi). Then at 48
hpi animals were washed several times and then transferred to a
fresh NGM/OP50 plate to remove external spores. Next, 50
animals were picked off of this plate into a microfuge tube with M9
and concentrated OP50, and rotated on a nutator for 16 hours.
The microfuge tube was removed from the nutator and incubated
without shaking for 10 minutes to allow the C. elegans, but not the
spores, to pellet to the bottom of the tube. Then the supernatant
was transferred to a new microfuge tube and the spores were
pelleted by spinning at high speed in a microfuge. The supernatant
was removed after this spin and the spores in the pellet were
stained with Calcofluor White and quantified with a hemocytom-
eter. The absolute number of spores shed per worm varied from
experiment to experiment. The viability of animals was confirmed
at the end of the assays and assays were performed in triplicate for
each experiment. Statistical comparisons of data were done with a
two-tailed t-test in Excel.
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Assays for integrity of intestinal cells was performed with a
propidium iodide assay, as described [31]. Briefly, YFP::ACT-5;
IFB-2::CFP animals were infected with 9.3610
5 spores on an
OP50-seeded 6cm NGM plate. Approximately 40 hours later,
animals were washed off the plate and put in a solution of 5-HT at
5 mg/ml for 15 minutes in order to force feed dye into animals –
Cry5B treatment causes animals to cease feeding. Animals were
then stained in a 20 mg/ml solution of propidium iodide for 30
minutes, washed twice with M9 to remove background excess dye,
and imaged using fluorescence microscopy at 630X. We scored
only animals that were at the ‘‘full spore’’ stage and therefore were
very likely contagious and actively shedding spores. Negative
control animals were treated similarly except they were not
infected with spores. Positive control Cry5B-treated animals were
plated as synchronized L1 larvae on NGM OP50 plates until they
reached the L4 stage. They were then washed onto NGM/
Ampicillin/IPTG plates seeded with OP50-Cry5B and incubated
at 25uC for 30 minutes. They were then washed off the plates and
treated as detailed above. In order to quantify the percentage of
animals exhibiting propidium iodide staining intracellularly, we
imaged animals with a defined exposure time and then measured
the maximum fluorescence intensity in the lumen and intracellu-
larly using ImageJ software from the NIH (http://rsb.info.nih.
gov/ij/). If the maximum fluorescence intensity was greater
intracellularly than in the lumen, the animal was binned as
exhibiting intracellular propidium iodide. Statistical comparisons
of data were done with a two-tailed t-test in Excel.
Accession Numbers
Accession numbers for the genes and gene products mentioned
in this paper are given for Wormbase, a publically available
database that can be accessed at http://www.wormbase.org.
These accession numbers are: act-5 (T25C8.2), ifb-2 (F10C1.7),
bec-1 (T19E7.3), pgp-1 (K08E7.9).
Supporting Information
Figure S1 Terminal web restructuring in IFB-2::CFP
single transgenic animals. Kinetics of terminal web restruc-
turing and parasite development in a population of animals
infected at time=0 hours. Data shown are the average of two
independent experiments with 50 animals scored at each time-
point in each experiment (for a total of at least 100 animals scored
at each timepoint). Error bars are SD.
(TIF)
Figure S2 Diluted RNAi against act-5 causes reduction
in YFP::ACT-5 expression. YFP::ACT-5; IFB-2::CFP animals
treated with control RNAi (A), 1:50 dilution of act-5 RNAi (B) and
1:25 dilution of act-5 RNAi (C). First column on left is images in
the YFP channel, second column is CFP channel, third column is
Nomarski bright-field and fourth column is an overlay of all three
channels. Images in YFP and CFP channels were taken with same
exposure time: note decreased level of YFP::ACT-5 signal with 1:50
act-5 RNAi and further decreased level with 1:25 act-5 RNAi.
Scale bar is 20 mm.
(TIF)
Figure S3 Nomarski images of animals analyzed for
cellular integrity. In order to illustrate intestinal cell morphol-
ogy, the same animals shown in Figure 8 A–F are shown in this
figure with Nomarski bright-field imaging in A–C and Nomarski
overlay with propidium iodide in red and autofluorescence in blue
D–F. Upward arrows in D–F indicate lumen. Arrowheads in C
indicate two examples of clusters of N. parisii spores, which are
false-colored green. Scale bar is 20 mm.
(TIF)
Table S1 Longitudinal studies of ACT-5 and IFB-2
changes in individual animals throughout infection.
(XLS)
Table S2 Analysis of IFB-2::CFP terminal web gap
number and size in a population of animals.
(XLS)
Table S3 Analysis of IFB-2::CFP terminal web gap
number and size in a longitudinal study of individual
animals.
(XLS)
Video S1 Relocalization of intestinal actin upon infec-
tion. Uninfected IN4000 YFP::ACT-5 animal: note the restriction
of YFP::ACT-5 to the apical membrane. Anterior is down, pharynx
is just outside of the field of view. Video plays through a Z-stack of
35 images taken every 0.5 mm in a single animal. Video starts at
the plane of focus toward the outside of the animal (similar to the
plane of focus in Figure 2C), and end at the plane of focus inside
the animal (similar to the plane of focus in Figure 2B). See
Figure 2D for more anatomical information.
(MOV)
Video S2 Relocalization of intestinal actin upon infec-
tion. N. parisii meront-infected IN4000 YFP::ACT-5 animal. Note
the extensive branched networks of ectopic YFP::ACT-5 in
basolateral regions. Lumen is slightly distended in this animal.
Anterior is to the right, pharynx is just outside of the field of view.
Video plays through a Z-stack of 35 images taken every 0.5 mmi n
a single animal. Video starts at the plane of focus toward the
outside of the animal (similar to the plane of focus in Figure 2C),
and end at the plane of focus inside the animal (similar to the plane
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